MYND Life Sciences (MYNDF) Financial Statements
MYND Life Sciences Financial Overview
MYND Life Sciences's market cap is currently $2.40M. The company's EPS TTM is $-0.01; its P/E ratio is -2.18; MYND Life Sciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jan 24 | Jan 23 | Jan 22 | Oct 20 | Oct 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -332.99K | $ -59.83K | $ -86.12K | $ 0.00 | $ 0.00 |
| Operating Income | $ -1.81M | $ -3.06M | $ -4.29M | $ -56.47K | $ -2.54K |
| EBITDA | $ -1.81M | $ -2.97M | $ -4.21M | $ 0.00 | $ 0.00 |
| Net Income | $ -1.52M | $ -3.57M | $ -4.37M | $ -56.47K | $ -2.54K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 257.00 | $ 412.00 | $ 1.90M | $ 0.00 | $ 0.00 |
| Total Assets | $ 797.54K | $ 654.12K | $ 2.67M | $ 70.00 | $ 0.00 |
| Total Debt | $ 3.00M | $ 2.59M | $ 2.32M | $ 0.00 | $ 0.00 |
| Net Debt | $ 3.00M | $ 2.59M | $ 423.36K | $ 0.00 | $ 0.00 |
| Total Liabilities | $ 5.77M | $ 4.19M | $ 2.74M | $ 53.69K | $ 1.83K |
| Stockholders' Equity | $ -4.98M | $ -3.53M | $ -67.97K | $ -53.62K | $ -1.83K |
| Cash Flow | |||||
| Free Cash Flow | $ -198.26K | $ -1.82M | $ -3.13M | $ -2.78K | $ -708.00 |
| Operating Cash Flow | $ -198.26K | $ -1.82M | $ -2.98M | $ -2.78K | $ -708.00 |
| Investing Cash Flow | $ 198.10K | $ -80.00K | $ 2.13M | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ 0.00 | $ 2.75M | $ 2.78K | $ 708.00 |
Currency in CAD
